Latest Headlines

Latest Headlines

Biotronik scores FDA approval for MRI-safe pacemaker system

Biotronik scored FDA approval for its next-generation, MRI-safe pacemaker system, continuing its winning streak for its implantable cardiac devices.

Biotronik proceeds with MRI-safe ICD study in the U.S. as initial patients join in

A few weeks after the FDA allowed Biotronik to expand its ProMRI trial to implantable cardioverter-defibrillators, the company hasn't wasted any time moving ahead. The German cardiac device company said it performed initial ICD surgeries for the study at hospitals in Connecticut, Pennsylvania, North Carolina, Michigan, Virginia, New York and Oregon, generally involving its Iforia devices.

Biotronik wins CE mark for new pacers that instantly broadcast patient problems to doctors

Biotronik has a CE mark in hand for its new Eluna pacemakers, made with MRI-compatible technology and other advances designed to help them stand out in an already-crowded, stagnant market.

FDA: Biotronik can expand its MRI-safe ICD trial

The FDA will allow Biotronik to expand its ProMRI trial in the U.S. to implantable cardioverter-defibrillators (ICD), making the German device maker first to the starting line to test whether a patient with an ICD can safely undergo a magnetic resonance imaging (MRI) scan.

Biotronik's drug-coated balloon builds on its promise as a treatment for leg blood clots

Germany's Biotronik said 6-month results from a broader study of a drug-coated balloon to treat leg blood clots showed a major boost in the standard of care compared to standard balloon angioplasty.

Germany's Biotronik wins a CE mark for a super-tiny, MRI-safe CRT lead

Germany's Biotronik said it gained a new CE mark for a bipolar cardiac resynchronization therapy lead that is super-small and MRI-safe.

Biotronik launches drug-releasing balloon Passeo-18 Lux in Europe

German devicemaker Biotronik launched its Passeo-18 Lux drug-releasing balloon in Europe, backed by stellar results.

Biotronik kicks off absorbable stent trial as market crowds

Germany's Biotronik has treated its first patient in a multi-center trial of its bioabsorbable vascular scaffold, a study aimed at winning a CE mark for the coronary artery disease-treating device.

Biotronik unveils next-gen MRI-safe ICDs

Germany's Biotronik is rolling out a new line of implantable cardioverter defibrillators meant to be safe for MRI use, an advance that has proliferated in Europe. The Berlin-based cardiac device company will start selling its Idova 7 implantable cardioverter defibrillators, which it bills as the most powerful ICDs approved for MR scanning. Initial implants have taken place in Austria and Italy.

Biotronik unveils longer versions of key hybrid stent

Germany's Biotronik is rolling out two longer lengths of one of its signature stents in a bid that could help it stand out in a very crowded field.